{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,5]],"date-time":"2026-07-05T14:42:38Z","timestamp":1783262558153,"version":"3.54.6"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"16","license":[{"start":{"date-parts":[[2024,4,19]],"date-time":"2024-04-19T00:00:00Z","timestamp":1713484800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,4,19]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Tachycardia\u2013bradycardia syndrome (TBS) is a subtype of sick sinus syndrome characterized by prolonged sinus pause (\u22653\u2009s) following termination of tachyarrhythmias, primarily atrial fibrillation (AF). There is controversy regarding whether the long-term prognosis of AF ablation is superior to pacemaker implantation. This study aimed to compare the effects of AF ablation and pacemaker therapy in patients with TBS.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>We conducted a comprehensive search of electronic databases, including PubMed, Cochrane, EmBase, Web of Science, and Chinese BioMedical, up until December 1, 2023. We included studies that reported the effects of AF ablation vs pacemaker therapy in patients with TBS. From this search, we identified 5 studies comprising 843 participants with TBS who underwent catheter AF ablation or pacemaker therapy.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Our meta-analysis revealed that AF ablation and pacemaker therapy had similar effects on cardiovascular death (odds ratio [OR]\u2005=\u20050.62 and 95% confidence interval [CI]: 0.14\u20132.65), procedural complications (OR\u2005=\u20051.53 and 95% CI: 0.67\u20133.48), and cardiovascular rehospitalization (OR\u2005=\u20050.57 and 95% CI: 0.26\u20131.22). However, AF ablation provided greater benefits than pacemaker therapy in terms of all-cause mortality (OR\u2005=\u20050.37 and 95% CI: 0.17\u20130.82), thromboembolism (OR\u2005=\u20050.25 and 95% CI: 0.12\u20130.49), stroke (OR\u2005=\u20050.28 and 95% CI: 0.13\u20130.57), heart failure (OR\u2005=\u20050.27 and 95% CI: 0.13\u20130.56), freedom from AF (OR\u2005=\u200523.32 and 95% CI: 7.46\u201372.92), and prevention of progression to persistent AF (OR\u2005=\u20050.12 and 95% CI: 0.06\u20130.24). Furthermore, AF ablation resulted in a reduced need for antiarrhythmic agents (OR\u2005=\u20050.21 and 95% CI: 0.08\u20130.59).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>AF ablation can effectively reduce the risk of all-cause mortality, thromboembolism, stroke, heart failure, and progression to persistent AF in patients with TBS. Additionally, it may eliminate the need for further pacemaker therapy in most cases after ablation. Therefore, AF ablation is considered superior to pacemaker therapy in the management of patients with TBS.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000037543","type":"journal-article","created":{"date-parts":[[2024,4,19]],"date-time":"2024-04-19T18:07:57Z","timestamp":1713550077000},"page":"e37543","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["Atrial fibrillation ablation compared to pacemaker therapy in patients with tachycardia\u2013bradycardia syndrome: A systematic review and updated meta-analysis"],"prefix":"10.1097","volume":"103","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-1308-9241","authenticated-orcid":false,"given":"Lijun","family":"Su","sequence":"first","affiliation":[{"name":"Department of Rehabilitation, ShunDe Hospital of Guangzhou University of Chinese Medicine, Foshan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqi","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Emergency, ShunDe Hospital of Guangzhou University of Chinese Medicine, Foshan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengguang","family":"Kang","sequence":"additional","affiliation":[{"name":"Department of Emergency, ShunDe Hospital of Guangzhou University of Chinese Medicine, Foshan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caidi","family":"Gong","sequence":"additional","affiliation":[{"name":"Department of Emergency, ShunDe Hospital of Guangzhou University of Chinese Medicine, Foshan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9522-1903","authenticated-orcid":false,"given":"Dezhu","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Emergency and Critical Care Medicine, ShunDe Hospital of Guangzhou University of Chinese Medicine, Foshan, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250503","doi-asserted-by":"crossref","first-page":"e42","DOI":"10.1161\/CIRCEP.113.000151","article-title":"Unusual tachycardia\u2013bradycardia syndrome during atrial fibrillation: what is the mechanism?","volume":"6","author":"Clementy","year":"2013","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"R2-20250503","doi-asserted-by":"crossref","first-page":"519","DOI":"10.3892\/ijmm.2017.2877","article-title":"Tachycardia\u2013bradycardia syndrome: electrophysiological mechanisms and future therapeutic approaches (Review).","volume":"39","author":"Tse","year":"2017","journal-title":"Int J Mol Med"},{"key":"R3-20250503","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1111\/j.1540-8167.2007.00825.x","article-title":"Incessant wide QRS tachycardia after pulmonary vein isolation and pacemaker implantation in a patient with tachycardia\u2013bradycardia syndrome.","volume":"18","author":"Lo","year":"2007","journal-title":"J Cardiovasc Electrophysiol"},{"key":"R4-20250503","first-page":"e382","article-title":"2018 ACC\/AHA\/HRS guideline on the evaluation and management of patients with bradycardia and cardiac conduction delay: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society.","volume":"140","author":"Kusumoto","year":"2019","journal-title":"Circulation"},{"key":"R5-20250503","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1161\/01.CIR.0000090685.13169.07","article-title":"Reverse remodeling of sinus node function after catheter ablation of atrial fibrillation in patients with prolonged sinus pauses.","volume":"108","author":"Hocini","year":"2003","journal-title":"Circulation"},{"key":"R6-20250503","first-page":"201","article-title":"Atrium-pulmonary vein isolation by radiofrequency ablation in patients with paraxysmal atrial fibrillation and sick sinus syndrome.","volume":"11","author":"Yang","year":"2003","journal-title":"Chin J Cardiac Arrhyth"},{"key":"R7-20250503","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1536\/ihj.48.247","article-title":"Pulmonary vein isolation for atrial fibrillation in patients with paroxysmal atrial fibrillation and prolonged sinus pause.","volume":"48","author":"Ohkubo","year":"2007","journal-title":"Int Heart J"},{"key":"R8-20250503","doi-asserted-by":"crossref","first-page":"e004549","DOI":"10.1161\/JAHA.112.004549","article-title":"Long-term outcomes of catheter ablation of atrial fibrillation: a systematic review and meta-analysis.","volume":"2","author":"Ganesan","year":"2013","journal-title":"J Am Heart Assoc"},{"key":"R9-20250503","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1093\/europace\/eut159","article-title":"The role of successful catheter ablation in patients with paroxysmal atrial fibrillation and prolonged sinus pauses: outcome during a 5-year follow-up.","volume":"16","author":"Inada","year":"2014","journal-title":"Europace"},{"key":"R10-20250503","doi-asserted-by":"crossref","first-page":"e445","DOI":"10.1016\/j.hrthm.2017.07.009","article-title":"2017 HRS\/EHRA\/ECAS\/APHRS\/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation: executive summary.","volume":"14","author":"Calkins","year":"2017","journal-title":"Heart Rhythm"},{"key":"R11-20250503","doi-asserted-by":"crossref","first-page":"646","DOI":"10.2459\/JCM.0000000000001360","article-title":"Catheter ablation for treatment of bradycardia-tachycardia syndrome: is it time to consider it the therapy of choice? A systematic review and meta-analysis.","volume":"23","author":"Magnano","year":"2022","journal-title":"J Cardiovasc Med (Hagerstown)"},{"key":"R12-20250503","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1365-2753.2010.01516.x","article-title":"Assessment of study quality for systematic reviews: a comparison of the Cochrane Collaboration Risk of Bias Tool and the Effective Public Health Practice Project Quality Assessment Tool: methodological research.","volume":"18","author":"Armijo-Olivo","year":"2012","journal-title":"J Eval Clin Pract"},{"key":"R13-20250503","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","article-title":"Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of observational studies in epidemiology (MOOSE) group.","volume":"283","author":"Stroup","year":"2000","journal-title":"JAMA"},{"key":"R14-20250503","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis.","volume":"21","author":"Higgins","year":"2002","journal-title":"Stat Med"},{"key":"R15-20250503","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"R16-20250503","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/pace.12340","article-title":"Pacing or ablation: which is better for paroxysmal atrial fibrillation-related tachycardia\u2013bradycardia syndrome?","volume":"37","author":"Chen","year":"2014","journal-title":"Pacing Clin Electrophysiol"},{"key":"R17-20250503","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1080\/00015385.2019.1630055","article-title":"Long-term effect of catheter ablation on tachycardia\u2013bradycardia syndrome: evidenced by 10 years follow up.","volume":"75","author":"Zhang","year":"2019","journal-title":"Acta Cardiol"},{"key":"R18-20250503","doi-asserted-by":"crossref","first-page":"998","DOI":"10.4070\/kcj.2020.0065","article-title":"Long-term clinical outcomes of radiofrequency catheter ablation versus permanent pacemaker implantation in patients with tachycardia\u2013bradycardia syndrome.","volume":"50","author":"Cho","year":"2020","journal-title":"Korean Circ J"},{"issue":"Suppl 2","key":"R19-20250503","first-page":"712","article-title":"Comparison catheter ablation versus permanent pacemaker implantation in patients with tachycardia\u2013bradycardia syndrome: prospective, randomized trial.","volume":"41","author":"Choi","year":"2020","journal-title":"Eur Heart J"},{"key":"R20-20250503","doi-asserted-by":"crossref","first-page":"674471","DOI":"10.3389\/fcvm.2021.674471","article-title":"Risk stratification for atrial fibrillation and outcomes in tachycardia\u2013bradycardia syndrome: ablation vs pacing.","volume":"8","author":"Zhang","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"R21-20250503","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1161\/CIRCULATIONAHA.113.001644","article-title":"Prospective randomized study to assess the efficacy of site and rate of atrial pacing on long-term progression of atrial fibrillation in sick sinus syndrome: septal pacing for atrial fibrillation suppression evaluation (SAFE) study.","volume":"128","author":"Lau","year":"2013","journal-title":"Circulation"},{"key":"R22-20250503","doi-asserted-by":"crossref","first-page":"7","DOI":"10.5603\/KP.a2014.0148","article-title":"Effectiveness of atrial versus atrioventricular pacing for sick sinus syndrome during long-term follow-up.","volume":"73","author":"Kuniewicz","year":"2015","journal-title":"Kardiol Pol"},{"key":"R23-20250503","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1093\/europace\/euw364","article-title":"Single lead atrial vs. dual chamber pacing in sick sinus syndrome: extended register-based follow-up in the DANPACE trial.","volume":"19","author":"Brandt","year":"2017","journal-title":"Europace"},{"key":"R24-20250503","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1136\/hrt.2003.016063","article-title":"Incidence of atrial fibrillation and thromboembolism in a randomised trial of atrial versus dual chamber pacing in 177 patients with sick sinus syndrome.","volume":"90","author":"Kristensen","year":"2004","journal-title":"Heart"},{"key":"R25-20250503","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1093\/europace\/euw073","article-title":"Antithrombotic therapy use in patients with atrial fibrillation before the era of non-vitamin K antagonist oral anticoagulants: the Global Registry on Long-Term Oral Antithrombotic Treatment in Patients with Atrial Fibrillation (GLORIA-AF) Phase I cohort.","volume":"18","author":"Huisman","year":"2016","journal-title":"Europace"},{"key":"R26-20250503","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1161\/01.RES.0000052672.97759.36","article-title":"Compound heterozygosity for mutations (W156X and R225W) in SCN5A associated with severe cardiac conduction disturbances and degenerative changes in the conduction system.","volume":"92","author":"Bezzina","year":"2003","journal-title":"Circ Res"},{"key":"R27-20250503","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s12872-018-0834-0","article-title":"Long-term clinical outcomes of catheter ablation in patients with atrial fibrillation predisposing to tachycardia\u2013bradycardia syndrome: a long pause predicts implantation of a permanent pacemaker.","volume":"18","author":"Kim","year":"2018","journal-title":"BMC Cardiovasc Disord"},{"key":"R28-20250503","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1016\/j.jacc.2018.02.048","article-title":"Clinical outcomes of his bundle pacing compared to right ventricular pacing.","volume":"71","author":"Abdelrahman","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"R29-20250503","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0735-1097(22)01032-4","article-title":"Delay in atrial fibrillation ablation for women with sinus node dysfunction and a higher incidence of the need for pacemaker implantation.","volume":"79","author":"Okumus","year":"2022","journal-title":"J Am Coll Cardiol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000037543","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T00:10:57Z","timestamp":1746317457000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000037543"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,19]]},"references-count":29,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000037543","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,19]]}}}